| Bartz, J. A., E. Hollander, et al. (2008). "Oxytocin and experimental therapeutics in autism spectrum disorders." Prog. Brain Res. Volume 170: 451-462. |
Beatrice and Samuel A. Seaver Foundation and NIMH |
3.253 |
| Boomsma, A., N. D. Van Lang, et al. (2008). "A new symptom model for autism cross-validated in an independent sample." J. Child Psychol. Psychiatry 49(8): 809-16. Epub 2008/05/22. |
ZonMw and the Korczak Foundation for autism and related disorders |
4.854 |
| Braunschweig, D., P. Ashwood, et al. (2008). "Autism: maternally derived antibodies specific for fetal brain proteins." Neurotoxicology 29(2): 226-31. Epub 2007/12/15. |
NIEHS, EPA, MIND |
2.409 |
| Danielsson, S., G. Viggedal, et al. (2008). "Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study." Epilepsy & Behavior: E&B 12(2): 298-304. |
GSK, the Margarethahemmet Foundation, and the Linne´a and Josef Carlsson Foundation |
2.302 |
| Dell, D. D., Feleccia, M., Hicks, L., Longstreth-Papsun, E., Politsky, S., & Trommer, C. (2008). "Care of patients with autism spectrum disorder undergoing surgery for cancer." Oncology Nursing Forum, 35(2): 177-182. |
None |
2.207 |
| Deokar, A. M., Huff, M. B., & Omar, H. A. (2008). "Clinical management of adolescents with autism." Pediatric Clinics of North America, 55(5): 1147-1157, viii. |
None |
1.270 |
| Ehninger, D., S. Han, et al. (2008). "Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis." Nat. Med. 14(8): 843-8. Epub 2008/06/24. |
Deutsche Forschungsgemeinschaft, NINDS, and Autism Speaks |
27.553 |
| Faja, S., E. Aylward, et al. (2008). "Becoming a face expert: a computerized face-training program for high-functioning individuals with autism spectrum disorders." Developmental neuropsychology 33(1): 1-24. |
NICHD, NIMH and the CAN |
1.964 |
| Foxx, R. M. (2008). "Applied behavior analysis treatment of autism: the state of the art." Child and Adolescent Psychiatric Clinics of North America, 17(4): 821-834, ix. |
None |
1.856 |
| Gencer, O., F. N. I. Emiroglu, et al. (2008). "Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study." Eur. Child Adolesc. Psychiatry 17(4): 217-25. |
Janssen and Cilag Drug Company |
1.769 |
| Gernsbacher MA, Sauer EA, Geye HM, Schweigert EK, Hill Goldsmith H. (2008). "Infant and toddler oral- and manual-motor skills predict later speech fluency in autism." J. Child Psychol. Psychiatry. 49(1):43-50. Epub 2007/11/01. |
NAAR and NIDCD |
4.854 |
| Goldberg, J., G. M. Anderson, et al. (2008). "Cortical Serotonin Type-2 Receptor Density in Parents of Children with Autism Spectrum Disorders." J. Autism Dev. Disord. Epub 2008/07/02. |
NAAR, HHSF, OMHF, Korczak Foundation for Autism Research and the Gettner Research Fund |
3.348 |
| Gothelf, D., J. A. Furfaro, et al. (2008). "Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP)." Ann. Neurol. 63(1): 40-51. |
NIMH |
9.935 |
| Hallahan, B., E. M. Daly, et al. (2008). "Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults." Psychol. Med.: 1-10. Epub 2008/09/09. |
MRC UK A.I.M.S. Network |
4.718 |
| Helt, M., E. Kelley, et al. (2008). "Can children with autism recover? If so, how?" Neuropsychol. Rev. 18(4): 339-66. Epub 2008/11/15. |
None |
3.349 |
| Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. (2008). "Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study." J Neuroinflammation. Nov 21;5:52. |
Jonty Foundation and the ARI |
3.206 |
| Kakooza-Mwesige, A., Wachtel, L. E., & Dhossche, D. M. (2008). "Catatonia in autism: implications across the life span." European Child and Adolescent Psychiatry, 17(6): 327-335. |
None |
1.769 |
| Knaus TA, Silver AM, Lindgren KA, Hadjikhani N, Tager-Flusberg H. (2008). "fMRI activation during a language task in adolescents with ASD." J. Int. Neuropsychol. Soc. 14(6):967-79. |
NIDCD, NICHD, NINDS and BUMC |
2.625 |
| Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). "Pharmacological treatment options for autism spectrum disorders in children and adolescents." Harvard Review of Psychiatry, 16(2): 97-112. |
None |
1.649 |
| Lian, W. B., S. H. K. Ying, et al. (2008). "Pre-school teachers' knowledge, attitudes and practices on childhood developmental and behavioural disorders in Singapore." J. Paediatr. Child Health 44(4): 187-94. |
None |
1.124 |
| Mandell DS (2008). "Psychiatric hospitalization among children with autism spectrum disorders." J Autism Dev Disord. 2008 Jul;38(6):1059-65. Epub 2007 Nov 2. |
NIMH, The Pennsylvania Department of Health |
3.348 |
| McDougle, C. J., Stigler, K. A., Erickson, C. A., & Posey, D. J. (2008). "Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders." Journal of Clinical Psychiatry, 69 Suppl 4, 15-20. |
NIMH, NCRR, Bristol-Myers Squibb, Jansses, Eli Lilly, and FRI |
5.053 |
| Meyer, U., M. Nyffeler, et al. (2008). "Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge." Neuropsychopharmacology 33(2): 441-456. |
SNF Grant, Grants of the Swiss Federal Institute of Technology |
6.835 |
| Montes G, and Halterman JS (2008). "Association of Childhood Autism Spectrum Disorders and Loss of Family Income." Pediatrics 2008; 121;e821-e826. |
None |
4.789 |
| Montgomery, P., E. Mayo-Wilson, et al. (2008). "Personal assistance for children and adolescents (0-18) with intellectual impairments." Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006858.pub2: 10.1002/14651858.CD006858.pub2 |
Centre for Evidence-Based Intervention, University of Oxford (UK), Unit for Disabilities Issues, The National Board of Health and Welfare (Sweden), The Institute for Evidence-Based Social Work Practice, The National Board of Health and Welfare (Sweden) |
5.182 |
| Morgan, A. T. and A. P. Vogel (2008). "Intervention for childhood apraxia of speech." Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006278. DOI: 10.1002/14651858.CD006278.pub2. |
Murdoch Childrens Research Institute (Australia) |
5.182 |
| Mouridsen, S. E., H. Bronnum-Hansen, et al. (2008). "Mortality and causes of death in autism spectrum disorders: an update." Autism 12(4): 403-14. Epub 2008/06/27. |
None |
1.937 |
| Nydén, A., K.-J. Myrén, et al. (2008). "Long-term psychosocial and health economy consequences of ADHD, autism, and reading-writing disorder: a prospective service evaluation project." Journal of Attention Disorders 12(2): 141-8. |
Eli Lilly and Swedish Inheritance Fund |
None listed |
| Parikh, M. S., Kolevzon, A., & Hollander, E. (2008). "Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability." Journal of Child and Adolescent Psychopharmacology, 18(2): 157-178. |
NIMH, FDA, and LRL |
2.641 |
| Politi, P., H. Cena, et al. (2008). "Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study." Arch. Med. Res. 39(7): 682-5. |
None |
1.703 |
| Rogers, S. J., & Vismara, L. A. (2008). "Evidence-based comprehensive treatments for early autism." J Clin Child Adolesc Psychol, 37(1): 8-38. |
NICHD, NIDCD, and NIMH |
2.928 |
| Siller M, Sigman M. (2008). "Modeling longitudinal change in the language abilities of children with autism: parent behaviors and child characteristics as predictors of change." Dev. Psychol. 44(6):1691-704. |
NICHD, NIMH, M.I.N.D Institute and Autism Speaks |
3.425 |
| Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW. (2008). "Antibodies against fetal brain in sera of mothers with autistic children." J Neuroimmunol. 2008 Feb;194(1-2):165-72. Epub 2008 Feb 21. |
NAAR |
3.159 |
| Tartaglia, N., S. Davis, et al. (2008). "A new look at XXYY syndrome: medical and psychological features." American Journal of Medical Genetics. Part A 146A(12): 1509-22. |
NIH LRP, Bonfils-Stanton Foundation, M.I.N.D. Institute, XXYY Project |
2.555 |
| Theoharides, T. C., & Doyle, R. (2008). "Autism, gut-blood-brain barrier, and mast cells." Journal of Clinical Psychopharmacology, 28(5): 479-483. |
Theta Biomedical Consulting and Development Co, Inc |
4.371 |
| Uddin, L. Q., M. S. Davies, et al. (2008). "Neural basis of self and other representation in autism: an FMRI study of self-face recognition." PLoS ONE 3(10): e3526. Epub 2008/10/30. |
NICHD, NCRR, NAAR, NSF, the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, Ahmanson Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, and Northstar Fund |
None listed |
| Waldman, H. B., Perlman, S. P., & Wong, A. (2008). "Providing dental care for the patient with autism." Journal - California Dental Association, 36(9): 662-670. |
None |
None listed |
| Walker, G. (2008). "Constant and progressive time delay procedures for teaching children with autism: a literature review." Journal of Autism and Developmental Disorders, 38(2): 261-275. |
None |
3.348 |
